Morgan Stanley’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$259K Buy
35,258
+21,228
+151% +$156K ﹤0.01% 5746
2025
Q1
$108K Sell
14,030
-1,211
-8% -$9.35K ﹤0.01% 5971
2024
Q4
$184K Sell
15,241
-2,981
-16% -$36.1K ﹤0.01% 5819
2024
Q3
$229K Buy
18,222
+10,949
+151% +$137K ﹤0.01% 5705
2024
Q2
$86.8K Buy
7,273
+1,567
+27% +$18.7K ﹤0.01% 6010
2024
Q1
$99.7K Buy
+5,706
New +$99.7K ﹤0.01% 5989
2023
Q4
Sell
-6,516
Closed -$47.1K 7858
2023
Q3
$47.1K Buy
6,516
+1,443
+28% +$10.4K ﹤0.01% 6192
2023
Q2
$26.8K Buy
5,073
+2,513
+98% +$13.3K ﹤0.01% 6462
2023
Q1
$7.95K Sell
2,560
-2,241
-47% -$6.96K ﹤0.01% 6948
2022
Q4
$19K Sell
4,801
-13
-0.3% -$51 ﹤0.01% 6711
2022
Q3
$18K Sell
4,814
-60
-1% -$224 ﹤0.01% 6833
2022
Q2
$65K Sell
4,874
-3,489
-42% -$46.5K ﹤0.01% 6492
2022
Q1
$41K Sell
8,363
-60,201
-88% -$295K ﹤0.01% 6793
2021
Q4
$470K Buy
68,564
+58,153
+559% +$399K ﹤0.01% 5592
2021
Q3
$321K Sell
10,411
-3,737
-26% -$115K ﹤0.01% 5745
2021
Q2
$458K Buy
14,148
+6,177
+77% +$200K ﹤0.01% 5579
2021
Q1
$302K Buy
7,971
+5,506
+223% +$209K ﹤0.01% 5420
2020
Q4
$116K Buy
2,465
+1,959
+387% +$92.2K ﹤0.01% 5850
2020
Q3
$16K Sell
506
-1,818
-78% -$57.5K ﹤0.01% 6137
2020
Q2
$103K Buy
2,324
+739
+47% +$32.8K ﹤0.01% 5383
2020
Q1
$52K Sell
1,585
-33
-2% -$1.08K ﹤0.01% 5452
2019
Q4
$83K Sell
1,618
-5,397
-77% -$277K ﹤0.01% 5705
2019
Q3
$258K Sell
7,015
-25,253
-78% -$929K ﹤0.01% 5002
2019
Q2
$1.78M Buy
32,268
+31,380
+3,534% +$1.73M ﹤0.01% 3866
2019
Q1
$54K Sell
888
-2,178
-71% -$132K ﹤0.01% 5631
2018
Q4
$181K Sell
3,066
-320
-9% -$18.9K ﹤0.01% 5320
2018
Q3
$273K Sell
3,386
-1,316
-28% -$106K ﹤0.01% 5312
2018
Q2
$412K Buy
4,702
+611
+15% +$53.5K ﹤0.01% 5224
2018
Q1
$792K Buy
4,091
+3,657
+843% +$708K ﹤0.01% 4712
2017
Q4
$44K Buy
434
+401
+1,215% +$40.7K ﹤0.01% 5862
2017
Q3
$1K Buy
+33
New +$1K ﹤0.01% 6445
2016
Q4
Sell
-1
Closed 6537
2016
Q3
$0 Sell
1
-120
-99% ﹤0.01% 6526
2016
Q2
$21K Buy
121
+31
+34% +$5.38K ﹤0.01% 5831
2016
Q1
$17K Buy
90
+3
+3% +$567 ﹤0.01% 5969
2015
Q4
$31K Sell
87
-74
-46% -$26.4K ﹤0.01% 5891
2015
Q3
$84K Sell
161
-47
-23% -$24.5K ﹤0.01% 5495
2015
Q2
$457K Sell
208
-24
-10% -$52.7K ﹤0.01% 4780
2015
Q1
$542K Buy
232
+12
+5% +$28K ﹤0.01% 4604
2014
Q4
$455K Sell
220
-29
-12% -$60K ﹤0.01% 4723
2014
Q3
$496K Buy
249
+13
+6% +$25.9K ﹤0.01% 4581
2014
Q2
$840K Buy
236
+90
+62% +$320K ﹤0.01% 4199
2014
Q1
$546K Buy
146
+57
+64% +$213K ﹤0.01% 4488
2013
Q4
$293K Buy
89
+31
+53% +$102K ﹤0.01% 4821
2013
Q3
$242K Sell
58
-90
-61% -$376K ﹤0.01% 4765
2013
Q2
$498K Buy
+148
New +$498K ﹤0.01% 4260